CDKN1A and thyroid gland carcinoma: The combination of hsa-miR-4732-5p and hsa-miR-1180-3p as an input for pathway analysis provided “thyroid cancer” as an altered pathway (P = 0.037, Table 4A), including MAP2K2, CDKN1A, and TRP as target genes.